U.S. FDA issues four observations to Piramal Pharma’s facility near Hyderabad
Form-483 with four observations
14 Feb 15:14 · The Hindu
U.S. FDA issues 9 observations to Aurobindo Pharma unit
The U.S. Food and Drug Administration (U.S. FDA) has issued nine observations to the oral solid dosage manufacturing unit of generic drugmaker Aurobindo Pharma near Hyderabad.
11 Feb 16:58 · The Hindu
U.S. FDA issues 11 observations to formulation unit of Aurobindo Pharma arm in Hyderabad
he U.S. Food and Drug Administration (U.S. FDA) has issued 11 observations to the formulation manufacturing facility of Aurobindo Pharma’s subsidiary Eugia Pharma Specialities in Hyderabad.
6 Feb 16:40 · The Hindu
last updated on 15 Feb 04:30